Month: March 2022

Las Vegas, NV, March 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Hemp, Inc. (OTC PINK: HEMP), one of the global leaders that has been on the forefront of the industrial hemp industry, reports today the U.S. House of Representatives may soon, possibly, vote to federally legalize marijuana.  On Wednesday, March 30, 2022 at 1:00pm EST, the House Rules Committee (the committee that considers all bills reported from policy and fiscal committees and determines whether, and in what order, to schedule their consideration on the floor of the House) will determine which amendments to H.R. 3617 (the MORE Act) will be allowed to advance to the House floor. Once it’s on the House floor, the MORE Act will be voted on, debated or amended and if passed by a simple majority, it will move to the Senate and undergo the same process. Why...

LOS ANGELES, March 28, 2022 (GLOBE NEWSWIRE) — Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading smart glass technology company, released a Form 8-K, disclosing entering into a Master Supply Agreement with a large Real Estate Investment Trust (REIT). Crown will supply its window tinting products to the client in selected locations in three states. The terms of the agreement will be disclosed in a future joint press release. Crown expects to achieve product launch in Summer 2022, as outlined in Mr. Doug Croxall Shareholder Letter on March 23rd, 2022. The potential market for Crown’s products targets US commercial office buildings. According to results from the U.S. Energy Information Administration’s (EIA) 2018 Commercial Buildings Energy Consumption Survey (CBECS), as of 2018...

The Company announces the sale of its building in Lyon in a sale and leaseback transaction worth over 20 million euros This transaction results in a net cash inflow of 19 million euros and is accompanied by the signature of a 12-year firm renewable lease With this non-dilutive transaction, Adocia has today a cash position of 28 million eurosLYON, France, March 28, 2022 (GLOBE NEWSWIRE) — Adocia (Euronext Paris : FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic solutions for the treatment of diabetes and other metabolic diseases, announced today the completion of the sale of its laboratory and office complex located in Lyon, France to a specialized investor. This financial transaction results in the sale of the building for more than 20 million euros and...

AVAILABILITY OF THE 2021 UNIVERSAL REGISTRATION DOCUMENT PARIS, MARCH 28, 2021 — Tarkett informs that it has filed its 2021 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on March 28, 2022. The 2021 Universal Registration Document is available to the public, free of charge under the conditions provided by applicable regulations and may be consulted on the “Investors” page of the Group’s website (www.tarkett.com). It is also available on the AMF’s website (www.amf-france.org). The 2021 Universal Registration Document includes:the 2021 Annual Financial Report; the Management Report from the Management Board; the Supervisory Board Report on Corporate Governance; the Social and Environmental Responsibility Report ; the Statutory Auditors reports and the information related to the fees paid to the Statutory...

NEW YORK and CLEVELAND, March 28, 2022 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that Vish Seshadri, Ph.D., Chief Executive Officer of Abeona Therapeutics, will participate in a panel discussion titled, “Cell Therapy: How the Definition has Expanded with Time, and the Potential Applications for Rare Diseases,” at the Cantor Fitzgerald Virtual Rare Disease Summit on Wednesday, March 30, 2022 at 4:00 p.m. ET. Those interested in participating in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit are encouraged to contact their Cantor Fitzgerald representative. About Abeona Therapeutics Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing gene and cell therapies for serious diseases. Abeona’s clinical programs include...

The financing of the company is ordinary for companies like Havila Kystruten.  The ships are financed through leasing agreements for an agreed period.  Havila Kystruten has purchase option for the ships after two years following the delivery of each ship and purchase obligation after 10 years. The financing of the company is through leasing companies registered in Hong Kong for Havila Capella and Havila Castor and in Ireland for Havila Polaris and Havila Pollux.  Since Havila Capella and Havila Castor is leased through companies outside EU, the company has applied for and got approval form the Ministry of Trade, Industry and Fisheries for registration of the ships in Norway.  Havila Capella is sailing under Norwegian flag in accordance with Norwegian legislation (Sjøloven).  Norwegian flag will also apply for all ships. The situation that...

Dallas, Texas, March 28, 2022 (GLOBE NEWSWIRE) — North American Cannabis Holdings, Inc. (OTC Pink: USMJ) today confirmed the company is scheduled to publish an update tomorrow with details on the recently announced plans that could add $20 million in sales on top of the company’s growing sales from its expanding ecommerce business.  The plan in general is to take advantage or the unexcepted opportunity to grow and sell adult use marijuana, in addition to also rapidly capturing the opportunity for USMJ’s recently acquired CBD sports nutrition beverage. USMJ has recently confirmed its eligibility to apply for the new adult-use marijuana cultivation license recently passed into law in the State of New York. In February, New York passed a new law to provide provisional marijuana cultivation licenses to existing hemp businesses.  USMJ...

EEZY PLC —   STOCK EXCHANGE RELEASE — 28 MARCH 2022 AT 17.20 The Board of Directors of Eezy Plc has resolved to extend the third earning period of the incentive plan for the key employees of the company Eezy Plc has on 30 November 2021 published information on the third earning period of the long-term incentive plan for the key employees of the company. Eezy Plc’s Board of Directors has today resolved to extend the third earning period of the incentive plan. The third earning period shall be 16 months, starting on 1 December 2021, and ending on 31 March 2023. According to the previous decision a maximum of 246.000 reward shares could be awarded for the third earning period, and the maximum dilution would be approx. 1.0%. The reward criteria for the third earning period are based on Eezy Plc’s revenue and operating profit...